| 000 | 01916cam a22003978i 4500 | ||
|---|---|---|---|
| 008 | 200624t2021 paua b 001 0 eng | ||
| 020 |
_a9781975139445 _qpaperback _cRM312.72 |
||
| 040 |
_aDNLM/DLC _beng _erda _cDLC _dUKM _erda |
||
| 090 |
_aQV736.AA1 _bR222e 2021 9 |
||
| 100 | 1 |
_aRascati, Karen L., _eauthor. |
|
| 245 | 1 | 0 |
_aEssentials of pharmacoeconomics : _bhealth economics and outcomes research / _cKaren L. Rascati. |
| 250 | _aThird edition. | ||
| 264 | 1 |
_aPhiladelphia : _bLippincott Williams & Wilkins, _c[2021]. |
|
| 264 | 4 | _c©2021. | |
| 300 |
_axvii, 360 pages : _billustrations ; _c26 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aMeasuring and estimating costs -- Critiquing research articles -- Cost-minimization analysis -- Cost-effectiveness analysis -- Cost-utility analysis -- Cost-benefit analysis -- Health-related quality of life : health status measures -- Decision analysis -- Markov modeling -- Real-world data/real-world evidence -- Budget-impact analyses -- Pharmacy services -- International perspective -- Future issues. | |
| 650 | 2 | _aEconomics, Pharmaceutical. | |
| 650 | 2 | _aCost-Benefit Analysis. | |
| 650 | 2 |
_aPharmaceutical Preparations _xeconomics. |
|
| 650 | 2 |
_aPharmaceutical Services _xeconomics. |
|
| 650 | 2 | _aTreatment Outcome. | |
| 650 | 2 | _aModels, Economic. | |
| 651 | 2 | _aUnited States. | |
| 907 |
_a.b16959425 _b2023-01-16 _c2022-11-08 |
||
| 942 |
_c01 _n0 _kQV736.AA1 R222e 2021 9 |
||
| 949 | _o900157378 | ||
| 990 | _afy | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _b2022-11-15 _cm _da _feng _gpau _y0 _z.b16959425 |
||
| 999 |
_c662849 _d662849 |
||